[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Abbott Laboratories Stock: Is ABT Underperforming the Healthcare Sector?

Valued at a market cap of $194.6 billion, Abbott Laboratories (ABT) is a global healthcare company that discovers, develops, manufactures, and sells a wide range of healthcare products across various segments. With operations in pharmaceuticals, diagnostics, nutrition, and medical devices, it serves diverse markets worldwide, including emerging and developed regions.

Companies worth over $10 billion are generally described as “large-cap” stocks, and Abbott Laboratories fits this criterion perfectly. Abbott is renowned for its innovative medical devices, particularly the FreeStyle Libre continuous glucose monitoring system, which revolutionized diabetes care.

Shares of the North Chicago, Illinois-based company have declined 19.7% from its 52-week high...

Fundamentals

See More
  • Market Capitalization, $K 194,616,176
  • Shares Outstanding, K 1,730,383
  • Annual Sales, $ 44,328 M
  • Annual Income, $ 6,524 M
  • EBIT $ 9,268 M
  • EBITDA $ 12,384 M
  • 60-Month Beta 0.59
  • Price/Sales 4.36
  • Price/Cash Flow 15.96
  • Price/Book 3.73

Options Overview Details

View History
  • Implied Volatility 27.27% (+2.92%)
  • Historical Volatility 22.05%
  • IV Percentile 63%
  • IV Rank 46.51%
  • IV High 37.47% on 07/15/26
  • IV Low 18.41% on 09/04/25
  • Expected Move (DTE 3) 2.25 (2.04%)
  • Put/Call Vol Ratio 0.41
  • Today's Volume 5,266
  • Volume Avg (30-Day) 10,271
  • Put/Call OI Ratio 0.57
  • Today's Open Interest 233,673
  • Open Int (30-Day) 239,816
  • Expected Range 108.11 to 112.61

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 29 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $1.43
  • Number of Estimates 8
  • High Estimate $1.46
  • Low Estimate $1.41
  • Prior Year $1.30
  • Growth Rate Est. (year over year) +10.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
104.20 +5.91%
on 08/05/26
117.34 -5.95%
on 08/24/26
+4.66 (+4.41%)
since 07/31/26
3-Month
85.60 +28.93%
on 06/01/26
117.34 -5.95%
on 08/24/26
+24.76 (+28.93%)
since 05/29/26
52-Week
81.97 +34.63%
on 05/11/26
137.49 -19.73%
on 09/22/25
-21.01 (-15.99%)
since 08/28/25

Most Recent Stories

More News
Abbott Laboratories Stock: Is ABT Underperforming the Healthcare Sector?

Despite Abbott Laboratories' underperformance relative to the healthcare sector over the past year, Wall Street analysts remain strongly optimistic about the stock’s prospects.

ABT : 110.36 (-1.88%)
XLV : 170.54 (-0.36%)
JNJ : 265.85 (-0.82%)
Abbott launches the first and only ready-to-feed liquid infant formula made with whole milk in the U.S. at similar price to its existing Similac powdered formula

ABBOTT PARK, Ill. , Aug. 31, 2026 /PRNewswire/ -- Parents looking for an infant formula made with whole milk now have a new option. Abbott (NYSE: ABT) today announced the launch of Similac ® ...

ABT : 110.36 (-1.88%)
Abbott's next-generation Amulet 360™ device receives CE Mark to treat people with atrial fibrillation at risk of stroke

ABBOTT PARK, Ill. , Aug. 27, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), the global healthcare leader, announced today it has received CE Mark for the Amulet 360™ Left Atrial Appendage (LAA) Occluder,...

ABT : 110.36 (-1.88%)
3 Dividend Aristocrats That Wall Street Loves

Even within the elite set of dividend growers, some Dividend Aristocrats stand out more than others.

LIN : 489.58 (+0.01%)
ABT : 110.36 (-1.88%)
WST : 341.11 (+1.08%)
Abbott reaches agreements to resolve a portion of litigation involving its specialty formulas for preterm infants

ABBOTT PARK, Ill. , Aug. 20, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) has reached agreements with three law firms to resolve the  Gill  case and claims involving approximately 2,000 other individuals...

ABT : 110.36 (-1.88%)
Abbott and NACHC launch nationwide Food for Health initiative to make nutritious food a core part of healthcare

ABBOTT PARK, Ill. and BETHESDA, Md. , Aug. 17, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) and the National Association of Community Health Centers (NACHC) announced a multi-year "food is medicine" effort...

ABT : 110.36 (-1.88%)
Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis

ABBOTT PARK, Ill. and ROSEMONT, Ill. , Aug. 12, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), the global healthcare leader, and the Big Ten Conference today announced the return of the "We Give Blood"...

ABT : 110.36 (-1.88%)
Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI

ABBOTT PARK, Ill. , Aug. 11, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced a first-of-its-kind partnership with Google Health to redefine how people understand and manage their health....

ABT : 110.36 (-1.88%)
Solventum Nears Inflection Point As It Begins to Unlock Value

Solventum shares gain on strong Q2 revenue, earnings, and cash flow, buybacks, and improved guidance, with analysts raising price targets amid a discounted valuation versus med/tech peers.

SOLV : 91.06 (-0.07%)
ABT : 110.36 (-1.88%)
JNJ : 265.85 (-0.82%)
Abbott Stock: Is Wall Street Bullish or Bearish?

Abbott has lagged behind the broader market over the past year, yet analysts remain highly bullish about the stock’s prospects.

ABT : 110.36 (-1.88%)
XLV : 170.54 (-0.36%)
$SPX : 7,686.14 (-0.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures...

See More

Key Turning Points

3rd Resistance Point 113.59
2nd Resistance Point 112.61
1st Resistance Point 111.49
Last Price 110.36
1st Support Level 109.39
2nd Support Level 108.41
3rd Support Level 107.29

See More

52-Week High 137.49
Fibonacci 61.8% 116.28
Last Price 110.36
Fibonacci 50% 109.73
Fibonacci 38.2% 103.18
52-Week Low 81.97

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.